Scan to Download
One power score. Smarter investment decisions
Inhibikase Therapeutics Inc
IKT1.640USD
+0.100+6.49%
終値 09/19, 16:00（ET）15分遅れの株価
USD0.000時間外取引 (ET)
122.21M時価総額
損失額直近12ヶ月PER
四半期
四半期+年間
四半期
年間
YOY
空白行を非表示にする
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
FY2018Q4
FY2018Q1
FY2017Q4
FY2017Q1
総売上高
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%1.00
991.33%79.57K
1676.71%116.41K
40.17%64.52K
3169.86%63.57K
-97.78%7.29K
-99.52%6.55K
-96.73%46.03K
-98.86%1.94K
771.71%328.46K
520.73%1.36M
419.66%1.41M
-29.07%170.42K
-69.72%37.68K
31.54%219.59K
-54.19%270.79K
-82.14%240.28K
--124.43K
--166.93K
-14.48%591.10K
68.68%1.35M
179.41%691.20K
--797.40K
--247.38K
収益
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%1.00
991.33%79.57K
1676.71%116.41K
40.17%64.52K
3169.86%63.57K
-97.78%7.29K
-99.52%6.55K
-96.73%46.03K
-98.86%1.94K
771.71%328.46K
520.73%1.36M
419.66%1.41M
-29.07%170.42K
-69.72%37.68K
31.54%219.59K
-54.19%270.79K
-82.14%240.28K
--124.43K
--166.93K
-14.48%591.10K
68.68%1.35M
179.41%691.20K
--797.40K
--247.38K
営業費用
121.57%11.19M
229.60%15.76M
193.60%12.93M
20.19%5.83M
-20.07%5.05M
0.06%4.78M
0.11%4.40M
7.26%4.85M
35.99%6.32M
1.98%4.78M
-12.79%4.40M
-5.82%4.52M
16.41%4.65M
16.22%4.69M
267.79%5.04M
584.28%4.80M
530.05%3.99M
397.34%4.03M
106.97%1.37M
-47.23%701.39K
-74.72%633.51K
-65.11%810.80K
-74.56%662.54K
--1.33M
--2.51M
188.93%2.32M
250.26%2.60M
88.50%804.27K
--743.49K
--426.67K
研究 & 開発費
71.37%5.27M
282.13%10.51M
139.55%7.19M
29.90%4.19M
-32.19%3.08M
-3.60%2.75M
-1.68%3.00M
8.18%3.23M
52.09%4.54M
-5.40%2.85M
-9.91%3.05M
-5.48%2.98M
25.17%2.98M
24.06%3.02M
1393.87%3.39M
2516.39%3.15M
805.27%2.38M
758.97%2.43M
-15.29%226.94K
-52.71%120.57K
-44.48%263.18K
-81.80%283.11K
-81.66%267.92K
--254.97K
--474.05K
165.81%1.56M
143.47%1.46M
127.84%585.29K
--600.12K
--256.89K
減価償却費、減耗費および償却費
267.76%24.16K
92.66%12.65K
-0.02%6.57K
-0.23%6.57K
-95.87%6.57K
30.24%6.57K
30.27%6.57K
291.61%6.58K
--159.20K
--5.04K
--5.04K
--1.68K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
営業利益
-121.57%-11.19M
-229.60%-15.76M
-193.60%-12.93M
-22.20%-5.83M
18.57%-5.05M
-1.43%-4.78M
-1.58%-4.40M
-5.67%-4.77M
-33.67%-6.20M
-1.60%-4.71M
14.01%-4.33M
-0.94%-4.51M
-76.53%-4.64M
-76.77%-4.64M
-319.83%-5.04M
-573.64%-4.47M
-534.99%-2.63M
-386.15%-2.63M
-184.38%-1.20M
44.90%-663.71K
82.30%-413.92K
68.83%-540.01K
66.46%-422.26K
---1.20M
---2.34M
-1432.40%-1.73M
-2435.42%-1.26M
36.94%-113.07K
--53.91K
---179.29K
営業外受取（支払）利息純額
営業外受取利息
----
----
----
----
----
----
----
----
----
----
----
--18.54K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
特別利益（損失）
--358.42K
--1.16M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
税引前利益
-99.93%-9.92M
-194.19%-13.68M
-190.40%-12.13M
-25.74%-5.78M
14.16%-4.96M
-3.84%-4.65M
2.36%-4.18M
-2.24%-4.60M
-24.53%-5.78M
3.51%-4.48M
15.13%-4.28M
-0.52%-4.49M
-76.01%-4.64M
-75.98%-4.64M
-317.36%-5.04M
-566.75%-4.47M
-524.88%-2.64M
-381.71%-2.64M
-180.92%-1.21M
44.69%-670.60K
82.00%-421.87K
68.47%-547.44K
66.00%-430.01K
---1.21M
---2.34M
-1289.25%-1.74M
-2933.61%-1.26M
32.68%-124.98K
--44.63K
---185.65K
税引後利益
-99.93%-9.92M
-194.19%-13.68M
-190.40%-12.13M
-25.74%-5.78M
14.16%-4.96M
-3.84%-4.65M
2.36%-4.18M
-2.24%-4.60M
-24.53%-5.78M
3.51%-4.48M
15.13%-4.28M
-0.52%-4.49M
-76.01%-4.64M
-75.98%-4.64M
-317.36%-5.04M
-566.75%-4.47M
-524.88%-2.64M
-381.71%-2.64M
-180.92%-1.21M
44.69%-670.60K
82.00%-421.87K
68.47%-547.44K
66.00%-430.01K
---1.21M
---2.34M
-1289.25%-1.74M
-2933.61%-1.26M
32.68%-124.98K
--44.63K
---185.65K
継続事業による純利益
-99.93%-9.92M
-194.19%-13.68M
-190.40%-12.13M
-25.74%-5.78M
14.16%-4.96M
-3.84%-4.65M
2.36%-4.18M
-2.24%-4.60M
-24.53%-5.78M
3.51%-4.48M
15.13%-4.28M
-0.52%-4.49M
-76.01%-4.64M
-75.98%-4.64M
-317.36%-5.04M
-566.75%-4.47M
-524.88%-2.64M
-381.71%-2.64M
-180.92%-1.21M
44.69%-670.60K
82.00%-421.87K
68.47%-547.44K
66.00%-430.01K
---1.21M
---2.34M
-1289.25%-1.74M
-2933.61%-1.26M
32.68%-124.98K
--44.63K
---185.65K
親会社株主に帰属する当期純利益
-99.93%-9.92M
-194.19%-13.68M
-190.40%-12.13M
-25.74%-5.78M
14.16%-4.96M
-3.84%-4.65M
2.36%-4.18M
-2.24%-4.60M
-24.53%-5.78M
3.51%-4.48M
15.13%-4.28M
-0.52%-4.49M
-76.01%-4.64M
-75.98%-4.64M
-317.36%-5.04M
-566.75%-4.47M
-524.88%-2.64M
-381.71%-2.64M
-180.92%-1.21M
44.69%-670.60K
82.00%-421.87K
68.47%-547.44K
66.00%-430.01K
---1.21M
---2.34M
-1289.25%-1.74M
-2933.61%-1.26M
32.68%-124.98K
--44.63K
---185.65K
普通株主に帰属する純利益
-99.93%-9.92M
-194.19%-13.68M
-190.40%-12.13M
-25.74%-5.78M
14.16%-4.96M
-3.84%-4.65M
2.36%-4.18M
-2.24%-4.60M
-24.53%-5.78M
3.51%-4.48M
15.13%-4.28M
-0.52%-4.49M
-76.01%-4.64M
-75.98%-4.64M
-317.36%-5.04M
-566.75%-4.47M
-524.88%-2.64M
-381.71%-2.64M
-180.92%-1.21M
44.69%-670.60K
82.00%-421.87K
68.47%-547.44K
66.00%-430.01K
---1.21M
---2.34M
-1289.25%-1.74M
-2933.61%-1.26M
32.68%-124.98K
--44.63K
---185.65K
基本的1株当たり利益
83.26%-0.11
79.17%-0.15
-10.81%-0.75
24.37%-0.65
40.47%-0.66
24.91%-0.73
33.37%-0.68
19.53%-0.86
-0.18%-1.11
11.59%-0.98
15.23%-1.02
-0.24%-1.07
-75.36%-1.10
29.81%-1.10
-37.50%-1.20
-117.31%-1.07
-74.15%-0.63
-348.44%-1.57
-336.93%-0.87
44.81%-0.49
82.01%-0.36
68.47%-0.35
75.03%-0.20
---0.89
---2.01
-1224.27%-1.11
-2772.40%-0.80
32.68%-0.08
--0.03
---0.12
希薄化後1株当たり利益
83.26%-0.11
79.17%-0.15
-10.81%-0.75
24.37%-0.65
40.47%-0.66
24.91%-0.73
33.37%-0.68
19.53%-0.86
-0.18%-1.11
11.59%-0.98
15.23%-1.02
-0.24%-1.07
-75.36%-1.10
29.81%-1.10
-37.50%-1.20
-117.31%-1.07
-74.15%-0.63
-348.44%-1.57
-336.93%-0.87
44.81%-0.49
82.01%-0.36
68.47%-0.35
75.03%-0.20
---0.89
---2.01
-1224.27%-1.11
-2772.40%-0.80
32.68%-0.08
--0.03
---0.12
1株当たり配当金
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
通貨単位
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
監査意見
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
